Synthesis 2015; 47(13): 1893-1898
DOI: 10.1055/s-0034-1380571
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Divalent Carbohydrate Mimetics by Reductive Amination with Enantiopure 1,2-Oxazines as Precursors

Joana Salta
Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany   Email:
Hans-Ulrich Reissig*
Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany   Email:
› Author Affiliations
Further Information

Publication History

Received: 24 February 2015

Accepted after revision: 23 March 2015

Publication Date:
29 April 2015 (online)


A direct approach to mono- and divalent carbohydrate mimetics starting from an enantiopure 1,2-oxazine derivative is described. After the Lewis acid induced rearrangement and subsequent reduction to provide the expected bicyclic 1,2-oxazine derivative as major component, a new tricyclic compound resulting from a different rearrangement pathway was isolated in small amounts. A smooth and optimized method for the hydrogenation of the bicyclic 1,2-oxazine derivative is presented, affording the desired aminopyran with d-idopyranose configuration. By reductive amination this aminopyran was connected with different aldehydes to furnish N-alkylated compounds. Reductive amination using 1,5-pentanedial resulted in the formation of a piperidine ring. With rigid aromatic dialdehydes the desired divalent compounds were obtained in good to excellent yields. Similar divalent carbohydrate mimetics were prepared from serinol.

Supporting Information

  • References

    • Selected reviews:
    • 1a Sears P, Wong C.-H. Angew. Chem. 1999; 111: 2446 ; Angew. Chem. Int. Ed. 1999, 38, 2300
    • 1b Gruner SA. W, Locardi E, Lohof E, Kessler H. Chem. Rev. 2002; 102: 491
    • 1c Werz DB, Ranzinger R, Herget S, Adibekian A, von der Lieth C.-W, Seeberger PH. ACS Chem. Biol. 2007; 2: 685
    • 1d Koester DC, Holkenbrink A, Werz DB. Synthesis 2010; 3217
    • 1e Cipolla L, Peri F. Mini Rev. Med. Chem. 2011; 11: 39
    • 2a Helms M, Schade W, Pulz R, Watanabe T, Al-Harrasi A, Fišera L, Hlobilová I, Zahn G, Reissig H.-U. Eur. J. Org. Chem. 2005; 1003

    • Reviews:
    • 2b Pfrengle F, Reissig H.-U. Chem. Soc. Rev. 2010; 39: 549
    • 2c Bouché L, Reissig H.-U. Pure Appl. Chem. 2012; 84: 23
    • 3a Al-Harrasi A, Reissig H.-U. Angew. Chem. 2005; 117: 6383 ; Angew. Chem. Int. Ed. 2005, 44, 6227
    • 3b Yekta S, Prisyazhnyuk V, Reissig H.-U. Synlett 2007; 2069
    • 3c Al-Harrasi A, Pfrengle F, Prisyazhnyuk V, Yekta S, Koóš P, Reissig H.-U. Chem. Eur. J. 2009; 15: 11632
  • 4 Dernedde J, Enders S, Reissig H.-U, Roskamp M, Schlecht S, Yekta S. Chem. Commun. 2009; 932
  • 5 Roskamp M, Enders S, Pfrengle F, Yekta S, Dekaris V, Dernedde J, Reissig H.-U, Schlecht S. Org. Biomol. Chem. 2011; 9: 7448
    • 6a Raffler NA, Rivera-Nieves J, Ley K. Drug Discov. Today Ther. Strateg. 2005; 2: 213
    • 6b Chang J, Patton JT, Sarkar A, Ernst B, Magnani JL, Frenette PS. Blood 2010; 116: 1779
    • 6c Schlemmer C, Wiebe C, Ferenc D, Kowalczyk D, Wedepohl S, Ziegelmüller P, Dernedde J, Opatz T. Chem. Asian J. 2014; 9: 2119
  • 7 Recent review on multivalency: Fasting C, Schalley CA, Weber M, Seitz O, Hecht S, Koksch B, Dernedde J, Graf C, Knapp E.-W, Haag R. Angew. Chem. 2012; 124: 10622; Angew. Chem. Int. Ed. 2012, 51, 10472
    • 8a Pfrengle F, Al-Harrasi A, Reissig H.-U. Synlett 2006; 3498
    • 8b Pfrengle F, Al-Harrasi A, Brüdgam I, Reissig H.-U. Eur. J. Org. Chem. 2009; 282
    • 9a Bouché L, Kandziora M, Reissig H.-U. Beilstein J. Org. Chem. 2014; 10: 213
    • 9b Salta J. Dissertation . Berlin; Freie Universität Berlin: 2014
    • 10a Periasamy M, Thirumalaikumar M. J. Organomet. Chem. 2000; 609: 137
    • 10b Ouyang LZ, Zhong H, Li ZM, Cao ZJ, Wang H, Liu JW, Zhu XK, Zhu M. J. Power Sources 2014; 269: 768
  • 11 Wu N, Li X, Xu X, Wang Y, Xu Y, Chen X. Lett. Org. Chem. 2010; 7: 11
  • 12 Schweiger RG. Carbohydr. Res. 1972; 21: 219